Woman Man | 18 years and more
- | Country :
- France
- | organs :
- Utérus
- | Specialty :
- Thérapies Ciblées
Extract
A phase II, open-label, randomized, multicenter trial of pazopanib (GW786034) in combination with lapatinib (GW572016) compared to pazopanib monotherapy and lapatinib monotherapy in subjects with Figo stage IVB or recurrent or persistent cervical cancer with zero or one prior chemotherapy regimen for advanced/recurrent disease.
Scientific Abstract
en cours d'intégration;